Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies

Anoosha Habibi, Maryse Etienne-Julan, Emmanuelle Bernit, Maria Dimopoulou, Pagona Flevari, Ersi Voskaridou, Narcisse Elenga, Estelle Jean-Mignard, Giovanna Cannas, Pablo Bartolucci

Blood (2023) 142 (Supplement 1): 2500.

https://doi.org/10.1182/blood-2023-178198

Published: 2023

Journal Articles

The Clinical Significance of the Glomerular Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Renal Function of Caucasian Patients with Compound Heterozygosity for Hb S and β-Thalassemia

Ioannis Papassotiriou, Anastasia Bartzeliotou, Pagona Flevari, Maria Dimopoulou, Charalambos Kapogiannis, Vassiliki Kappou, Veroniki Komninaka, Konstantina Repa, Aimilia Mantzou, Alexandra Margeli, Eleni Pergantou, Christos Poziopoulos, Ersi Voskaridou

Blood (2022) 140 (Supplement 1): 8254–8255.

https://doi.org/10.1182/blood-2022-155859

Published: 2022

Journal Articles

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Blood (2022) 140 (Supplement 1): 12016–12017.

https://doi.org/10.1182/blood-2022-169972

Published: 2022

Journal Articles

Non Invasive Evaluation of Bone Marrow Activity in Patients with Sickle Cell Disease: Correlation with Disease Features, Genotype, Markers of Erythropoiesis, Iron Metabolism and Hydroxyurea Treatment

Ioannis Papassotiriou, PhD, Pagona Flevari, MD, Christos Poziopoulos, MD, Sofia Zaliou, PhD, Vasilis Tsaousis, PhD, Katerina Larissi, MD, Maria Dimopoulou, MD, Veroniki Komninaka, MD, Marianna Politou, MD, Evangelos Terpos, MD, Ersi Voskaridou

Blood (2019) 134 (Supplement_1): 4821.

https://doi.org/10.1182/blood-2019-121622

Published: 2019

Journal Articles

Soluble P-Selectin Levels in Patients with Sickle Cell Disease Reflect Platelets' Activation Rather Than Endothelial Dysfunction

Ersi Voskaridou, Mantzou Aimilia, PhD, Pagona Flevari, MD, Maria Dimopoulou, MD, Veroniki Komninaka, MD, Konstantina Repa, MD, Ioannis Papassotiriou, PhD

Blood (2019) 134 (Supplement_1): 4829.

https://doi.org/10.1182/blood-2019-122524

Published: 2019

Journal Articles

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Ioannis Papassotiriou, PhD, Katerina Larrisi, MD, Alexandra Margeli, PhD, Dimitrios Christoulas, Maria Dimopoulou, MD, Vaughn Ostland, PhD, Christos Poziopoulos, Mark Westerman, PhD, Marianna Politou, MD, Ersi Voskaridou, MD, Evangelos Terpos, MD PhD

Blood (2016) 128 (22): 3646.

https://doi.org/10.1182/blood.V128.22.3646.3646

Published: 2016

Journal Articles

Iron Overload of the Kidneys of Patients with Thalassemia and Sickle-Cell Disease: Final Results of a Prospective Study in 224 Patients Using Magnetic Resonance Imaging T2 and R2* Techniques

Ersi Voskaridou, Dimitrios Christoulas, Maria Dimopoulou, Konstantina Repa, Maroussa Douskou, Evangelos Terpos

Blood (2015) 126 (23): 2157.

https://doi.org/10.1182/blood.V126.23.2157.2157

Published: 2015

Journal Articles

Targeted Metabolomic Profiles Are Strongly Correlated With Metabolic Alterations In Patients With Sickle Cell/Beta Thalassemia Disease

Ioannis Papassotiriou, Fottes Panetsos, PhD, Theodora Livadara, MSc, Maria Dimopoulou, MD, Andreas Tzivaras, BSc, Ersi Voskaridou, MD

Blood (2013) 122 (21): 4675.

https://doi.org/10.1182/blood.V122.21.4675.4675

Published: 2013

Journal Articles

Circulating Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle-Cell/Beta-Thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density

Ersi Voskaridou, Dimitrios Christoulas, Maria Dimopoulou, Veroniki Komninaka, Maria Tsalkani, Athanasios Papatheodorou, Evangelos Terpos

Blood (2012) 120 (21): 3256.

https://doi.org/10.1182/blood.V120.21.3256.3256

Published: 2012

Journal Articles

Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients

Christina H. Kalpadakis, MD, Gerassimos Pangalis, Theodoros P. Vassilakopoulos, Sotirios P. Sachanas, MD, Flora Kontopidou, Xanthi Yiakoumis, MD, Styliani Kokoris, Evangelia Dimitriadou, Maria Dimopoulou, Maria Moschogiannis, MD, Penelope Korkolopoulou, Marie-Christine Kyrtsonis, Marina Siakantaris, M.D., Helen A. Papadaki, Maria K. Angelopoulou

Blood (2011) 118 (21): 2712.

https://doi.org/10.1182/blood.V118.21.2712.2712

Published: 2011

Journal Articles

Liver Transient Elastography (FibroScan) Correlates with Liver Iron Concentration and Reflects Liver Fibrosis In Patients with Sickle Cell Disease

Ersi Voskaridou, Maria Schina, Eleni Plata, Dimitrios Christoulas, Maria Tsalkani, Maria Dimopoulou, Hlectra Dimitrakopoulou, George Mousoulis, Evangelos Terpos

Blood (2010) 116 (21): 1646.

https://doi.org/10.1182/blood.V116.21.1646.1646

Published: 2010

Journal Articles

T Cell Depletion with Alemtuzumab Is Associated with a High Incidence of EBV Viraemia but Low Risk of PTLD Following Allogeneic Stem Cell Transplantation

Ben Carpenter, MD, Maria Dimopoulou, MD, Nilusha Manji, Tanzina Haque, MD, Claire Atkinson, MD, Sarah Grace, Stephen Mackinnon, MD, Ronjon Chakraverty, MD

Blood (2008) 112 (11): 1177.

https://doi.org/10.1182/blood.V112.11.1177.1177

Published: 2008

Journal Articles

De-Escalation of the Alemtuzumab Dose Prior to Nonmyeloablative HLA-Identical Sibling Transplantation: Crucial Role of Timing.

Ronjon Chakraverty, MD, Maria Dimopoulou, MD, Julie Glanville, MD, Kirsty Thomson, MD, Karl Peggs, MD, Donald Milligan, MD, Gordon Cook, MD, Graham Jackson, MD, Anne Parker, MD, Ann Hunter, MD, Nigel Russell, MD, Rachel Pearce, Stephen Mackinnon, MD

Blood (2006) 108 (11): 2901.

https://doi.org/10.1182/blood.V108.11.2901.2901

Published: 2006

NARROW

Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies

The Clinical Significance of the Glomerular Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Renal Function of Caucasian Patients with Compound Heterozygosity for Hb S and β-Thalassemia

The Prognostic Significance of Serum Beta-2 Microglobulin (sβ 2 m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs

Non Invasive Evaluation of Bone Marrow Activity in Patients with Sickle Cell Disease: Correlation with Disease Features, Genotype, Markers of Erythropoiesis, Iron Metabolism and Hydroxyurea Treatment

Soluble P-Selectin Levels in Patients with Sickle Cell Disease Reflect Platelets' Activation Rather Than Endothelial Dysfunction

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Iron Overload of the Kidneys of Patients with Thalassemia and Sickle-Cell Disease: Final Results of a Prospective Study in 224 Patients Using Magnetic Resonance Imaging T2 and R2* Techniques

Targeted Metabolomic Profiles Are Strongly Correlated With Metabolic Alterations In Patients With Sickle Cell/Beta Thalassemia Disease

Circulating Activin-A Is Elevated in Patients with Thalassemia Major and Double Heterozygous Sickle-Cell/Beta-Thalassemia and Correlates with Markers of Hemolysis and Bone Mineral Density

Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients

Liver Transient Elastography (FibroScan) Correlates with Liver Iron Concentration and Reflects Liver Fibrosis In Patients with Sickle Cell Disease

T Cell Depletion with Alemtuzumab Is Associated with a High Incidence of EBV Viraemia but Low Risk of PTLD Following Allogeneic Stem Cell Transplantation

De-Escalation of the Alemtuzumab Dose Prior to Nonmyeloablative HLA-Identical Sibling Transplantation: Crucial Role of Timing.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only